This information is intended for healthcare professionals based in Belgium and Luxembourg.
If you are not a healthcare professional, click here
NEW
BMS satellite symposium
From Treatment to Tissue:
Decoding Pathological Responses
to Cancer Immunotherapy
BMS satellite symposium
Traps of PD-L1 scoring
in advanced melanoma
%20banana_2.png)
A PD-L1 debate among pathologists:
Emerging trends on PD-L1 testing in MIUC
and Upper GI cancers
Upper GI and CPS:
A Ping Pong game between
a Pathologist and an Oncologist
PD-L1 testing
overview for BMS assets
Useful links
ImmunoScience Academy
An educational multi-disciplinary platform on immunology and immunotherapy
BSP poster
PD-L1 testing
accross tumor indications
SCCHN, squamous cell cancer of the head and neck; irAE(s), immune-related adverse event(s)
You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.
